Narayan Nair
Impact in
- Health top 5%
- Vaccine Coverage and Hesitancy
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Health 3
- Vaccine Coverage and Hesitancy 3
-
- Intramuscular injections and effects 3
- Co-authors
- Tom T. Shimabukuro (7 shared papers)Paige Marquez (9 shared papers)John R. Su (7 shared papers)Jane Baumblatt (2 shared papers)Julianne Gee (3 shared papers)Kerry J. Welsh (3 shared papers)Tanya R. Myers (3 shared papers)Bicheng Zhang (3 shared papers)
- Journals
- JAMA (3 papers)Vaccine (3 papers)MMWR Morbidity and Mortality Weekly Report (2 papers)Pharmacoepidemiology and Drug Safety (2 papers)JAMA Network Open (1 paper)
- Partner nations
- United StatesUgandaBrazil
In The Last Decade
Narayan Nair
17 papers receiving 846 citations
Narayan Nair's Hit Papers
Peers
Comparison fields: 5 of 92
- Health 173
- Infectious Diseases 386
- Emergency Medicine 80
- Neurology 100
- Hematology 71
Countries citing papers authored by Narayan Nair
This map shows the geographic impact of Narayan Nair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narayan Nair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narayan Nair more than expected).
Fields of papers citing papers by Narayan Nair
This network shows the impact of papers produced by Narayan Nair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narayan Nair. The network helps show where Narayan Nair may publish in the future.
Co-authors
The 25 scholars most cited alongside Narayan Nair, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021 Hit paper breakdown → | 2021 | 279 |
| 2 | Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine Hit paper breakdown → | 2021 | 229 |
| 3 | 2021 | 104 | |
| 4 | 2021 | 82 | |
| 5 | 2019 | 47 | |
| 6 | 2023 | 44 | |
| 7 | 2018 | 32 | |
| 8 | 2019 | 14 | |
| 9 | 2023 | 8 | |
| 10 | 2022 | 7 | |
| 11 | 2005 | 5 | |
| 12 | 2023 | 3 | |
| 13 | 2025 | 3 | |
| 14 | 2023 | 2 | |
| 15 | 2024 | 2 | |
| 16 | 2024 | 2 | |
| 17 | 2024 | 1 |
About Narayan Nair
Narayan Nair is a scholar working on Health, Emergency Medicine, Surgery, Pharmacology and Neurology, having authored 17 papers that have together received 864 indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (3 papers), Intramuscular injections and effects (3 papers), Heparin-Induced Thrombocytopenia and Thrombosis (2 papers), Peripheral Neuropathies and Disorders (2 papers), Respiratory viral infections research (2 papers), Drug-Induced Adverse Reactions (2 papers), Food Allergy and Anaphylaxis Research (2 papers) and Allergic Rhinitis and Sensitization (1 paper). The work is most often cited by research in Health (173 citations), Infectious Diseases (386 citations), Emergency Medicine (80 citations), Neurology (100 citations) and Hematology (71 citations). Narayan Nair has collaborated with scholars based in United States, Uganda and Brazil. Frequent co-authors include Tom T. Shimabukuro, Paige Marquez, John R. Su, Jane Baumblatt, Julianne Gee, Kerry J. Welsh, Tanya R. Myers, Bicheng Zhang, Emily Jane Woo and Mark J. Sotir. Their work appears in journals such as JAMA, Vaccine, MMWR Morbidity and Mortality Weekly Report, Pharmacoepidemiology and Drug Safety and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.